“…As expected, antibodies to CD31 stained endothelial cells in both large and small vessels, whereas PAL-E staining was largely confined to microvascular (Parums et al, 1990) ϩϩϩ ϩϩϩ 0 0 PAL-E, Sanbios, Netherlands (Schlingemann et al, 1985) Ϯ ϩϩϩ 0 0 Pericytes/smooth muscle cells Desmin, DAKO, ϩϩϩ ϩϩϩ 0 0 mAb clone D33 (Van Muijen et al, 1987) Smooth muscle ␣-actin, Sigma, ϩϩϩ ϩϩϩ 0 0 mAb clone 1A4 (Skalli et al, 1986) ␣11 integrin, T cell diagnostics, Woburn, Massachusetts, ϩ ϩϩϩ 0 0 mAb clone TS2/7 (Hemler, 1990) ␣ and ␥-actin, DAKO, ϩ ϩϩϩ 0 0 mAb clone HHF35 (Gown et al, 1986) Calponin, Sigma, ϩϩϩ Ϯ 0 0 mAb clone hCP Smooth muscle myosin, Sigma, ϩϩϩ ϩ 0 0 mAb clone hSM-V (Longtine et al, 1985) HMW-MAA, Sanbios, Netherlands ϩ 0 0 0 mAb clone NKI-M6 (Natali et al, 1981) PDGF -receptor, 0 0 0 0 mAb Clone PDGFR- 2 (Heldin et al, 1988) Fibroblasts Procollagen type 1 c-propeptide, 0 0 0 0 Biogenesis, Sandown, New Hampshire (MacDonald et al, 1986) Prolyl-4-hydroxylase, DAKO 0 0 0 0 mAb clone 5B5 (Höyhtyä et al, 1984) Pericytes and fibroblasts ASO2, Dianova, Hamburg, Germany Ϯ b ϩϩ ϩϩϩ 0 mAb clone ASO2 (Saalbach et al, 1996) Epithelium Cytokeratin, Sigma (Gigi-Leitner et al, 1986) 0 0 0 ϩϩϩ a 0, no positive cells; Ϯ, Ͻ10% of cells positive; ϩ, 10% to 40% of cells positive; ϩϩ, 40% to 70% of cells positive; ϩϩϩ, 70% to 90% of cells positive. b A few cells in the smooth muscle layer stained intensely for ASO2, whereas most smooth muscle cells were negative.…”